{"organizations": [], "uuid": "6b7d43b5fb9a92e8626fa96827e60cb217952a72", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://ethixbase.com/wp-content/uploads/2018/05/hypera-pharma-640x335.jpg", "site_section": "https://ethixbase.com/feed", "section_title": "ethiXbase", "url": "https://www.reuters.com/article/hypera-investigation/brazils-hypera-in-talks-for-leniency-deal-could-pay-540-mln-fine-paper-idUSL2N1SO284", "country": "US", "domain_rank": 408, "title": "Brazil: Brazil’s Hypera in talks for leniency deal, could pay $540 mln fine -paper", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "blogs", "published": "2018-05-18T14:30:00.000+03:00", "replies_count": 0, "uuid": "6b7d43b5fb9a92e8626fa96827e60cb217952a72"}, "author": "huizhi", "url": "https://www.reuters.com/article/hypera-investigation/brazils-hypera-in-talks-for-leniency-deal-could-pay-540-mln-fine-paper-idUSL2N1SO284", "ord_in_thread": 0, "title": "Brazil: Brazil’s Hypera in talks for leniency deal, could pay $540 mln fine -paper", "locations": [], "entities": {"persons": [{"name": "hypera", "sentiment": "none"}], "locations": [{"name": "south america", "sentiment": "none"}, {"name": "americas", "sentiment": "none"}, {"name": "brazil", "sentiment": "none"}, {"name": "sao paulo", "sentiment": "none"}, {"name": "hypera", "sentiment": "none"}], "organizations": [{"name": "hypera sa", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "valor economico", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 18th, 2018 Americas , South America\nBrazilian pharmaceutical company Hypera SA is in talks to agree to a leniency deal with prosecutors that could include a 2 billion reais ($540 million) fine, the company is set to admit to paying bribes for tax benefits, newspaper Valor Economico reported on Thursday, an agreement that Hypera denied.\nIn a statement sent to Reuters, Hypera denied “having negotiated any leniency agreement with prosecutors.” Federal prosecutors did not immediately comment.\nLast month, police raided the Sao Paulo offices of Hypera, Brazil’s largest listed producer of over the counter medicines, as part of a corruption investigation.\nThis article has been summarised, the www.reuters.com", "external_links": ["https://ethixbase.com/eanews/category/ethical-alliance-daily-news/south-america/", "https://ethixbase.com/eanews/category/ethical-alliance-daily-news/americas/"], "published": "2018-05-18T14:30:00.000+03:00", "crawled": "2018-05-18T14:50:38.013+03:00", "highlightTitle": ""}